Device

Drug spending projected to grow at 6% clip through 2024, spurred in part by pricey new medications; FDA approves new obesity device; Sanofi diabetes combo drug is better at reducing blood glucose than Lantus.

Sanofi is re-upping its social media-driven Data Design Diabetes Innovation Challenge contest, which last year kicked up a wealth of innovative ideas and buzz for the price of $200,000 in prize money and a few salaries.

Sanofi-Aventis US is rolling out a consumer campaign for its Lantus SoloStar pen aimed at getting people with type 2 diabetes to think differently about insulin, while Novo Nordisk revs up another racing-themed social media effort for its FlexPen.

Email Newsletters

MM&M KOL White Paper

MM&M News Brief

MM&M Sponsored Promotion

MM&M Weekly Digest

The Splash from MM&M

As US pharma continued its quest for a Grand
Prix at the Lions Health international festival of
creativity, MM&M went on location to Cannes,
France. Missed our coverage from June? Now,
we're giving you an opportunity to catch up on
some of what you missed. Download our
e-book on the two-day festival, recapping the
event, rounding up the best of the speakers,
offering perspective and listing all of the
winners. Click hereto download.

The most recent MM&M Skill Sets Live event
surveyed a range of issues relating to one of
the hottest promotional spaces in healthcare.
Speakers and panelists at the morning-long
session, including promotional- and
multichannel-minded executives from GSK,
Epocrates, Treato and Montefiore Medical
Center, weighed in on topics designed to help
marketers demystify the challenges associated
with non-personal promotion. Click here.